ClearPoint Neuro, Inc.
CLPT
$13.18
$0.483.78%
| Weiss Ratings | CLPT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | E | |||
| Rating Factors | CLPT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Fair | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Excellent | |||
| Total Return Index | Fair | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | CLPT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 1.48 | |||
| Price History | CLPT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -2.73% | |||
| 30-Day Total Return | -26.53% | |||
| 60-Day Total Return | -19.78% | |||
| 90-Day Total Return | 1.23% | |||
| Year to Date Total Return | -15.19% | |||
| 1-Year Total Return | 117.85% | |||
| 2-Year Total Return | 68.76% | |||
| 3-Year Total Return | 64.54% | |||
| 5-Year Total Return | 227.05% | |||
| 52-Week High % Change | -33.92% | |||
| 52-Week Low % Change | 148.78% | |||
| Price | CLPT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $19.22 | |||
| 52-Week Low Price | $5.11 | |||
| 52-Week Low Price (Date) | Apr 29, 2024 | |||
| 52-Week High Price (Date) | Feb 06, 2025 | |||
| Valuation | CLPT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 350.93M | |||
| Enterprise Value | 334.39M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -0.70 | |||
| Earnings Per Share Growth | -22.16% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 11.16 | |||
| Price/Book (Q) | 13.81 | |||
| Enterprise Value/Revenue (TTM) | 10.65 | |||
| Price | $13.18 | |||
| Enterprise Value/EBITDA (TTM) | -17.82 | |||
| Enterprise Value/EBIT | -16.93 | |||
| Market Cap Category | Small Cap | |||
| Dividends and Shares | CLPT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 27.59M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | CLPT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 888 287 9109 | |||
| Address | 120 S. Sierra Avenue Solana Beach, CA 92075 | |||
| Website | www.clearpointneuro.com | |||
| Country | United States | |||
| Year Founded | 1998 | |||
| Profitability | CLPT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -62.90% | |||
| Profit Margin | -60.25% | |||
| Management Effectiveness | CLPT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -30.16% | |||
| Return on Equity | -- | |||
| Income Statement | CLPT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 31.39M | |||
| Total Revenue (TTM) | 31.39M | |||
| Revenue Per Share | $1.14 | |||
| Gross Profit (TTM) | 19.12M | |||
| EBITDA (TTM) | -18.77M | |||
| EBIT (TTM) | -19.75M | |||
| Net Income (TTM) | -18.91M | |||
| Net Income Avl. to Common (TTM) | -18.91M | |||
| Total Revenue Growth (Q YOY) | 14.11% | |||
| Earnings Growth (Q YOY) | -16.61% | |||
| EPS Diluted (TTM) | -0.70 | |||
| EPS Diluted Growth (Q YOY) | -4.05% | |||
| Balance Sheet | CLPT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 20.10M | |||
| Cash Per Share (Q) | $0.73 | |||
| Total Current Assets (Q) | 33.36M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 25.39M | |||
| Current Ratio (Q) | 3.223 | |||
| Book Value Per Share (Q) | $0.92 | |||
| Total Assets (Q) | 39.19M | |||
| Total Current Liabilities (Q) | 10.35M | |||
| Total Debt (Q) | 3.57M | |||
| Total Liabilities (Q) | 13.80M | |||
| Total Common Equity (Q) | 25.39M | |||
| Cash Flow | CLPT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -275.00K | |||
| Cash from Financing (TTM) | 6.19M | |||
| Net Change in Cash (TTM) | -3.04M | |||
| Levered Free Cash Flow (TTM) | -1.19M | |||
| Cash from Operations (TTM) | -8.95M | |||
